BAL 8557,
BAL-8557,
BAL8557,
Cresemba,
isavuconazole,
isavuconazonium sulfate,
Isavuconazole,
241479-67-4,
isavuconazol,
BAL 4815,
BAL-4815,
UNII-60UTO373KE,
Isavuconazole [INN],
60UTO373KE,
Isavuconazole(BAL-4815; RO-0094815),
RO 0094815,
RO-0094815,
CHEBI:85979,
Isavuconazole (INN),
1286730-05-9,
4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile,
4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile,
4-[2-[(1R,2R)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1,2,4-triazol-1-yl)propyl]thiazol-4-yl]benzonitrile,
Bal4815,
isavuconazolum,
AC1OCFHQ,
BAL-8557(pro-drug),
SCHEMBL939038,
CHEMBL409153,
DTXSID2058251,
ASP9766,
DDFOUSQFMYRUQK-RCDICMHDSA-N,
BCP07587,
EX-A1785,
KS-00000T6L,
ZINC1485935,
3748AH,
MFCD06407745,
AKOS027250772,
AN-1203,
API0013809,
CS-3492,
SB16703,
NCGC00390646-01,
AS-30128,
HY-14273,
SC-98350,
FT-0670421,
Isavuconazole; BAL-4815; RO-0094815,
D10750,
J-015363,
(2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-1-(1H-1,2,4-triazol-1-yl)-2-(2,5-difluorophenyl)-butan-2-ol,
2R,3R)-3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile,
4-{2-[(1R,2R)-2-(2,5-Difluoro-phenyl)-2-hydroxy-1-methyl -3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl}-benzonitrile,
4-{2-[(1R,2R)-2-(2,5-Difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl }-benzonitrile,
4-{2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile,
Benzonitrile, 4-[2-[(1R,2R)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-,
Cresemba (TN),
D07VHS,
C22H17F2N5OS,
BAL8557,
BAL 8557,
ACN-040800,
CID6918485,